AAA
EPZM

Affinity Asset Advisors’s Epizyme, Inc EPZM Stock Holding History

Affinity Asset Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50,000
Closed -$436K – 85
2021
Q1 		$436K Buy
+50,000
New +$517K 0.15% 65

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Affinity Asset Advisors's EPZM Position: Q2 2021 in Review

Affinity Asset Advisors sold out of Epizyme, Inc (EPZM) in Q2 2021, closing a stake of 50,000 shares — an estimated $436K sold.

Affinity Asset Advisors first reported a position in EPZM in Q1 2021 and held it in 1 quarter. The position peaked at $436K in Q1 2021. 126 funds tracked by Wall St. Rank hold EPZM as of Q2 2021.

  • Affinity Asset Advisors reported no remaining Epizyme, Inc position as of Q2 2021 after selling out during the quarter.
  • Affinity Asset Advisors sold 50,000 Epizyme, Inc shares in Q2 2021, an estimated $436K.
  • Affinity Asset Advisors first reported a position in Epizyme, Inc in Q1 2021 and held it in 1 quarter.
  • Affinity Asset Advisors's Epizyme, Inc position peaked at $436K in Q1 2021.
  • 126 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2021.

Based on Affinity Asset Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.